Infectious mononucleosis: symptoms and treatment

Infectious mononucleosis is an infectious disease caused by the Epstein Bar virus, which causes a series of basic symptoms.

The mononucleosis it is popularly known as the "kissing disease". It is characterized mainly by being a pathology certainly little known, although it has a higher incidence of what is actually believed.

Explained in a more or less simple way, we can indicate that the mononucleosis It is an infectious water disease, exclusive of the human being and produced by the Epstein-Barr virus (EBV).

Regarding your own treatment of mononucleosis In itself, as we will see in detail below, the specialists maintain that it tends to heal itself, since currently there is no vaccine and the administration of medication does not diminish neither the symptoms nor the rest time.

Symptoms of mononucleosis

The mononucleosis It is characterized by having a series of symptom more or less basic or common, which should be taken into account:

  • Fever.
  • Fatigue.
  • Headache.
  • Discomfort or discomfort of the throat.
  • Asthenia.
  • Fatigue.
  • Loss of appetite
  • Muscle pains.
  • Increase in the size of the lymph nodes (especially the neck).
  • Increase in the size of the liver (rare).

Treatment of mononucleosis

As we mentioned before, there is currently no vaccine that can help prevent the appearance of mononucleosis.

Just as there is no Pharmacotherapy It helps when it comes to reducing your annoying symptoms, as well as reducing the resting time.

For this reason, the best treatment is to maintain absolute rest and drink plenty of fluids. In case there may be muscle pain or fever, ibuprofen or paracetamol may be useful.

When the disease has subsided, surely your doctor will request a periodic blood test to see how it evolves. This article is published for informational purposes only. It can not and should not replace the consultation with a Physician. We advise you to consult your Trusted Doctor. ThemesInfections

What You Don’t Know About Mono (April 2024)